AK

Arati Kumari

Director Director DIN 09013492
DIN 09013492 First appointment Dec 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2020
Shareholding value Locked Premium profile

About Arati Kumari

Data last updated:

Arati Kumari has 5 years in corporate governance. Formerly with 1 company, such as Wonicy Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09013492
Primary Designation Director
First Appointment 29 Dec 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Wonicy Pharma Private Limited U85100BR2020PTC049841
Director29 Dec 20202020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Wonicy Pharma Private Limited
Premium access

Shareholding and investment profile for Arati Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arati Kumari

Arati Kumari has 5 years in corporate governance. Formerly with 1 company, such as Wonicy Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Arati Kumari is associated with 0 companies as a director.

Arati Kumari has expertise in General Business.

Arati Kumari has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available